Multiply Labs, a San Francisco, CA-based developer of a 3D printing tech platform to make nutraceutical products, raised $2.7m in venture capital funding.
The round was led by P101, with participation from CRCM, Graph Ventures and Fenox Venture Capital.
The company, which had previously raised di $120k from Y Combinator and its partners, intends to use the funds to continue to build an advanced production facility where client orders will be received and realized on demand via a dosage robotic system.
Co-founded by a team MIT and University of Milan researchers including Federico Parietti, CEO, and Alice Melocchi (CTO) and accelerated within Y Combinator, Multiply Labs has developed a 3D Printing technology which can print customized pills for nutraceutical use.
The company’s platform enables the production of single pills, whose content in terms of supplements and active principles is personalized based on the unique metabolic needs of the patients.